The test will help to identify the antibodies of SARS-CoV-2, the virus strain that causes the disease, in the individuals who have developed an immune response to the virus.
Currently, Siemens Healthineers is working to receive emergency use authorisation (EUA) from the US Food and Drug Administration (FDA).
The company aims to make the Covid-19 test available by late next month, while its manufacturing facility in Walpole, Massachusetts, US, is expected to deliver more than 25 million tests per month from June.
